CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 77 filers reported holding CHEMOCENTRYX INC in Q2 2016. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $614,000 | +60.7% | 65,553 | +27.1% | 0.24% | +136.3% |
| Q4 2016 | $382,000 | +267.3% | 51,561 | +198.1% | 0.10% | +308.0% |
| Q3 2016 | $104,000 | +121.3% | 17,298 | +66.6% | 0.02% | +177.8% |
| Q2 2016 | $47,000 | -66.7% | 10,386 | -81.7% | 0.01% | -55.0% |
| Q1 2016 | $141,000 | +51.6% | 56,709 | +359.4% | 0.02% | +122.2% |
| Q1 2015 | $93,000 | -35.9% | 12,343 | -50.3% | 0.01% | -18.2% |
| Q2 2014 | $145,000 | – | 24,817 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |